Prof. Kimberly Watson, University of Reading
 

Structural and Computational Biology for Systems Biology
The lectures will be structured according to the following schedule: Structural Biology and Computational Biology. The integration of advanced imaging technologies and computational science with basic molecular and cellular research offers insight into how living systems function, thus giving rise to the science of systems biology. This short lecture series will look at the main experimental technologies and computational approaches, in use and under development, in order to understand complex biological systems at the molecular level. Structural Biology. Proteins make up about half of the material within the body's cells. They are involved in all essential life functions. A detailed analysis of protein-protein and protein-ligand interactions is a crucial goal for systems biology and, determination of three-dimensional protein structure is particularly important to proteomic research, since subtle changes in structure can affect the proper function of a protein, changing its activity, and possibly leading to its instability and ultimate destruction by the cell. The lectures will cover the major techniques and state-of-the-art strategies used in structural biology research, including structural genomics initiatives. Computational Biology. Another goal of systems biology is to develop a computer model of an entire cell. Such a model would revolutionise drug development, allowing the most promising drugs to be identified more quickly and in a more rational, informed way. Development of computational methods, informed and supported by experimental data, for 'in silico' testing and discovery of new drugs would help speed the drug discovery process and, most certainly, help eliminate early poor drug candidates. We will explore some key developments in the area of computational biology targeted toward prediction of three-dimensional protein structure, both protein-protein and protein-ligand interactions, particularly relevant to the drug discovery process.